<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Allogeneic hematopoietic stem cell transplantation for severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> from an alternative donor is associated with higher risks of graft rejection and severe <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We developed a conditioning regimen consisting of rabbit anti-thymocyte globulin, fludarabine, <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, and low-dose total body irradiation </plain></SENT>
<SENT sid="2" pm="."><plain>Two adult female patients with transfusion-dependent very severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> underwent 1-locus mismatched transplantation using this regimen </plain></SENT>
<SENT sid="3" pm="."><plain>Both patients achieved stable engraftment and the clinical course thereafter was uneventful with persistently <z:mpath ids='MPATH_458'>normal</z:mpath> ovarian function </plain></SENT>
<SENT sid="4" pm="."><plain>This novel conditioning regimen may be suitable for alternative donor transplantation for severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, especially in young female patients </plain></SENT>
</text></document>